Postoperative or Post-Traumatic Infections DRG 858

DRG 858 encompasses postoperative or post-traumatic infections requiring operating room procedures without Complication or Comorbidity or Major Complication or Comorbidity; it defines the clinical scope of admissions assigned to this payment group. Accurate coding and documentation of procedures and comorbid conditions matter because assignment to this Diagnosis-Related Group influences Medicare inpatient reimbursement and hospital case mix classification.

DRG 858 Overview

DRG 858 covers inpatient stays for postoperative or post-traumatic infections that require operating room procedures and do not have a Complication or Comorbidity or a Major Complication or Comorbidity. This Diagnosis-Related Group captures cases where surgical intervention is performed for infection control but the patient’s record lacks additional coded complications that would increase reimbursement. It matters for Medicare inpatient payment because assignment to this DRG determines base payment relative to other infection-related groups and affects hospital case mix and revenue for surgical infection care.

Acute surgical intervention and antimicrobial timing studies: randomized or pragmatic trials testing different intraoperative and immediate postoperative strategies for source control and timing/duration of broad-spectrum antibiotics in patients undergoing operative management of postoperative or post-traumatic infections. These studies enroll adult surgical inpatients with documented wound, deep soft tissue, or intra‑abdominal infections following a prior operation or traumatic injury and compare outcomes such as time to infection resolution, need for re‑operation, length of stay, and emergence of resistant organisms. Results inform surgical teams and hospital administrators on protocols that may shorten inpatient stays, reduce readmissions, and optimize antibiotic stewardship, all of which impact DRG resource use and reimbursement risk.
Comparative effectiveness trials of wound management and adjunctive therapies: head‑to‑head studies that evaluate alternative operative adjuncts (for example negative pressure wound therapy versus standard dressing strategies, or different debridement techniques) and non‑systemic adjuncts (topical antiseptics, local antimicrobial delivery) in patients with post‑operative or post‑traumatic infections requiring OR procedures. These trials typically include heterogeneous surgical populations (orthopedic, general, and trauma surgery patients) and measure wound healing rates, reoperation frequency, functional outcomes, and cost per episode of care. Payers and hospital case‑management teams use these findings to determine which operative and perioperative wound‑care pathways reduce complications and costly downstream resource use within this DRG.
Post‑discharge outcomes and health‑services research: observational cohort studies and pragmatic trials assessing post‑acute care pathways, readmission predictors, and long‑term functional outcomes for patients discharged after OR procedures for postoperative or post‑traumatic infections. Studies often link inpatient clinical data to post‑discharge utilization (home health, skilled nursing, outpatient antibiotics) and patient‑reported outcomes to identify drivers of 30‑ and 90‑day readmissions and total episode‑of‑care costs. This research is relevant to quality improvement, bundled payment models, and DRG reconciliation because it identifies modifiable factors that reduce costly readmissions and improve value across the full care episode.

Acute surgical intervention and antimicrobial timing studies: randomized or pragmatic trials testing different intraoperative and immediate postoperative strategies for source control and timing/duration of broad-spectrum antibiotics in patients undergoing operative management of postoperative or post-traumatic infections. These studies enroll adult surgical inpatients with documented wound, deep soft tissue, or intra‑abdominal infections following a prior operation or traumatic injury and compare outcomes such as time to infection resolution, need for re‑operation, length of stay, and emergence of resistant organisms. Results inform surgical teams and hospital administrators on protocols that may shorten inpatient stays, reduce readmissions, and optimize antibiotic stewardship, all of which impact DRG resource use and reimbursement risk.
Comparative effectiveness trials of wound management and adjunctive therapies: head‑to‑head studies that evaluate alternative operative adjuncts (for example negative pressure wound therapy versus standard dressing strategies, or different debridement techniques) and non‑systemic adjuncts (topical antiseptics, local antimicrobial delivery) in patients with post‑operative or post‑traumatic infections requiring OR procedures. These trials typically include heterogeneous surgical populations (orthopedic, general, and trauma surgery patients) and measure wound healing rates, reoperation frequency, functional outcomes, and cost per episode of care. Payers and hospital case‑management teams use these findings to determine which operative and perioperative wound‑care pathways reduce complications and costly downstream resource use within this DRG.
Post‑discharge outcomes and health‑services research: observational cohort studies and pragmatic trials assessing post‑acute care pathways, readmission predictors, and long‑term functional outcomes for patients discharged after OR procedures for postoperative or post‑traumatic infections. Studies often link inpatient clinical data to post‑discharge utilization (home health, skilled nursing, outpatient antibiotics) and patient‑reported outcomes to identify drivers of 30‑ and 90‑day readmissions and total episode‑of‑care costs. This research is relevant to quality improvement, bundled payment models, and DRG reconciliation because it identifies modifiable factors that reduce costly readmissions and improve value across the full care episode.

OpenPayer

Summary & Overview

Postoperative or Post-Traumatic Infections with O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 858 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes